Illinois Municipal Retirement Fund Has $26.41 Million Stock Position in CME Group Inc. $CME

Illinois Municipal Retirement Fund raised its holdings in CME Group Inc. (NASDAQ:CME) by 65.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 96,714 shares of the financial services provider’s stock after buying an additional 38,147 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in CME Group were worth $26,411,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Asset Dedication LLC grew its holdings in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. FNY Investment Advisers LLC acquired a new stake in shares of CME Group during the 4th quarter worth approximately $27,000. Hilton Head Capital Partners LLC acquired a new stake in shares of CME Group during the 4th quarter worth approximately $28,000. Legacy Wealth Managment LLC ID grew its holdings in shares of CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares in the last quarter. Finally, Global Wealth Strategies & Associates grew its holdings in shares of CME Group by 1,250.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 100 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Price Performance

Shares of CME stock opened at $263.80 on Thursday. The stock’s fifty day simple moving average is $286.00 and its 200 day simple moving average is $288.28. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market cap of $95.59 billion, a price-to-earnings ratio of 22.51, a P/E/G ratio of 2.86 and a beta of 0.21. CME Group Inc. has a one year low of $244.56 and a one year high of $329.16.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, beating the consensus estimate of $3.11 by $0.25. The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.CME Group’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.80 EPS. On average, analysts expect that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 2.0%. CME Group’s payout ratio is currently 44.37%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on CME shares. The Goldman Sachs Group decreased their price objective on CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a report on Thursday, April 23rd. Raymond James Financial lifted their price objective on CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a report on Monday, April 6th. Weiss Ratings reissued a “buy (a-)” rating on shares of CME Group in a report on Friday, May 29th. Rothschild & Co Redburn decreased their price objective on CME Group from $340.00 to $316.00 and set a “neutral” rating on the stock in a report on Monday, April 27th. Finally, Piper Sandler lifted their price objective on CME Group from $313.00 to $329.00 and gave the stock an “overweight” rating in a report on Wednesday, April 15th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $305.29.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group launched Nasdaq CME Crypto Index futures, a regulated cash-settled product tied to a benchmark of major cryptocurrencies including Bitcoin, Solana, XRP and others. The new offering could attract more trading volume from investors seeking broad crypto exposure and hedging tools. Article Title
• Positive Sentiment: CME Group and Morningstar announced an exclusive multi-year licensing agreement to launch derivatives based on Morningstar equity index benchmarks, opening a new product line tied to indexes that underpin more than $3 trillion in linked assets. Article Title
• Positive Sentiment: Shareholders maintained CME’s Class B governance structure and rejected a bid to end those director election rights, removing a potential governance overhang and preserving the company’s current control framework. Article Title
• Neutral Sentiment: CME also announced its second-quarter 2026 earnings release date for July 22, which is mainly a scheduling update but keeps attention on upcoming results. Article Title
• Neutral Sentiment: Reports about short interest and options activity suggest traders are watching CME closely, but those items do not yet point to a clear fundamental catalyst. Article Title

Insider Activity at CME Group

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the sale, the general counsel owned 7,192 shares of the company’s stock, valued at $2,397,597.04. The trade was a 31.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer directly owned 55,630 shares in the company, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 44,044 shares of company stock valued at $13,297,507 in the last 90 days. 0.30% of the stock is owned by corporate insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.